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Abstract
In this chapter, the immense contribution of nucleic acid discovery to the diagnosis
and molecular epidemiology of pathogenic microorganisms and its relevance for
veterinary and human health will be discussed. The development of nucleic acid
detection, amplification, and sequencing techniques, principally after the introduc‐
tion  of  polymerase  chain  reaction  (PCR),  allowed the  improvement  of  different
strategies to diagnose and to quantify infectious microbiological agents in a variety
of  organisms  and  biological  samples.  Pos-PCR  associated  techniques  such  as
fragment  enzyme restriction  and sequence  analysis  permit  the  determination  of
nucleic  acid  sequence  diversity  to  detect  drug  resistance,  to  associate  pathogen
genetic  markers  with  disease  outcome,  and  to  predict  temporal  and  spatial
distribution of microorganisms which can be used to prevent and treat infectious
diseases efficiently.
The principal methods used in the detection of nucleic acids, the advantages and
drawbacks of single- and multiple-copy genes for use in diagnosis by amplification,
and the application of pos-PCR techniques in drug resistance identification are dis‐
cussed in Section 1.1. Section 1.2 discusses the sequencing methods used to recog‐
nize genetic variability, the implication of this variability to pathology and
virulence, and the importance of genetic variability determination in disease control
and vaccines. The contribution of molecular diagnosis and epidemiology for the
treatment and prevention of infectious diseases is also considered.
Keywords: Infectious diseases, molecular diagnosis, PCR, real-time PCR, molecular epi‐
demiology, sequencing methods
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1. Introduction
1.1. Diagnosis
Several  infectious  diseases  caused  by  microorganisms,  including  protozoans  (malaria,
leishmaniasis,  trypanosomiasis,  amoebiasis,  etc.),  bacteria  (cholera,  gastritis  and  gastric
ulcers,  meningitis,  tuberculosis,  leprosy,  etc.),  and  viruses  (dengue  fever,  yellow  fever,
influenza, chikungunya fever, ebola, human immunodeficiency syndrome, etc.), are threats
to  public  health.  In  order  to  control  outbreaks,  emergence,  and  reemergence  of  these
infectious diseases, diagnosis, correct identification, treatment, and notification of pathogen‐
ic agents are necessary.
Classical clinical microbiological diagnostics for protozoan and bacteria rely on microscop‐
ic  examination  with  different  staining  methods,  culture  isolation,  morphological  and
physiological/biochemical characterization. For viruses, the conventional diagnosis is based
on  culture  isolation  of  cell  monolayer,  serological  assays,  and  electronic  microscopic
examination.  These  standard  diagnostic  methods  are  very  useful,  and  culture  isolation
associated with other analytical procedures to identify microorganisms continues to be the
gold standard method since  it  enables  drug sensitivity  tests.  However,  these  diagnostic
techniques  are  unsuitable  for  several  microorganisms  presenting  fastidious  growth
characteristics, low morphological and physiological specificity, and requirement of specific
biosafety infrastructure.  The same is applied to viruses that,  even after culture isolation,
can only be  visualized by electronic  microscopy,  which is  expensive and needs special‐
ized personnel to maneuver. Thus, nucleic acid detection by hybridization and amplifica‐
tion technologies opened a new and innovative period for microbial diagnosis. After the
first report on the application of polymerase chain reaction (PCR) in clinical diagnosis of
the  human  immunodeficiency  virus  (HIV)  [1],  several  other  infectious  organisms  were
detected by the same technique and its variations (Section 1.1.1).
In all molecular detection techniques, the gene target is the main device, and its choice depends
on the infectious agent and the host genomic and epidemiological characteristics. For a specific
diagnosis, the gene of choice has to be specific to the infectious agent and should not cross-
hybridize with the host genome and other organisms living in the same microhabitat. A
sensitive diagnosis depends on the amount of gene target copies in the biological sample and
to the physico-chemical characteristics of the constituents implicated in the detection and
amplification of gene target. A discussion about the use of single- and multiple-copy genes for
specific gene target amplification will be presented in Section 1.1.2.
The detection of drug resistance is dependent on sensitivity tests performed on the isolated
microorganism,  which  is  time  consuming;  however,  for  several  uncultivable  pathogenic
agents,  it  is  not  feasible.  The  investigation  of  nucleotide  mutations  associated  to  drug
resistance  allows  the  development  of  gene  target  amplification  and  post-amplification
analytical  techniques,  such  as  enzyme  restriction  analysis  and  sequencing,  to  be  used
directly on the biological infected sample, thereby enabling fast detection of drug resist‐
ance and consequently an efficient treatment.  The same strategy can be used to identify
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organisms from closed biological  groups,  with identical  morphological  characteristics on
microscopic examination and with different genetic features. Examples of nucleic acid drug
resistance detection techniques used in microbiological clinical laboratories will be present‐
ed in Section 1.1.3.
1.1.1. Nucleic acid detection methods
Originally, the nucleic acids were detected mainly by gene cloning strategies and hybridization
procedures [2], which are laborious and time consuming, being restricted to scientific inves‐
tigation. The use of nucleic acid detection for the diagnosis of genetic and infectious diseases
in clinical laboratories was possible after the advent of PCR [3], a technique based on ampli‐
fication of nucleic acids by means of thermostable polymerase enzymes and a thermocycler.
By this method, typically, DNA duplex templates are melted at high temperatures, and two
oligonucleotides complementary to the flanking gene target sequence are specifically annealed
in a strict temperature dependent on the primer sequence and length. Variations of the
technique includes the utilization of a set of oligonucleotides in order to identify different
organisms or variants in a single reaction on a biological sample [4-7]. Also, to increase
sensitivity and specificity, a nested and hemi/semi-nested PCR can be performed using an
initial PCR product as template [8, 9, 6, 10].
Besides PCR, the most largely used nucleic acid amplification device, isothermal amplifica‐
tion  techniques  based  on  enzymes  required  during  the  cellular  process  of  DNA/RNA
synthesis were also developed and are accessible for diagnosis and scientific investigation
as transcription-mediated amplification (TMA), nucleic acid sequence-based amplification
(NASBA),  signal-mediated  amplification  of  RNA  technology  (SMART),  strand  displace‐
ment  amplification  (SDA),  rolling  circle  amplification  (RCA),  loop-mediated  isothermal
amplification  of  DNA (LAMP),  isothermal  multiple  displacement  amplification  (IMDA),
helicase-dependent amplification (HDA), single primer isothermal amplification (SPIA), and
circular helicase-dependent amplification (cHDA). The description of these methods is out
of  the  scope  of  this  chapter,  and  several  revision  articles  can  be  consulted  for  more
information [11-13].
Subsequent to amplification, PCR products are traditionally visualized by an electrophoresis
in agarose or acrylamide gels following staining with fluorescent dyes and exposition to UV
light. By this method, the specificity of the amplified nucleic acid fragment is determined by
size, directly or after digestion with restriction enzymes in order to get more accurate infor‐
mation about the product obtained. The specificity of PCR products can also be determined
by sequencing (Section 1.2.2) and hybridization with chemically, fluorescently, or radioac‐
tively labeled specific probes as exemplified by the means of human papillomavirus (HPV)
genotyping [14, 15].
A novel improvement in nucleic acid amplification was achieved after the development of
PCR in the presence of fluorescent dyes, enabling the detection of products by amplification
cycle and, at real time, the real-time PCR [16]. Thermocycles developed for the real-time PCR
are associated to a fluorescence detection system and software to facilitate interpretation of
data at real time. Although conventional PCR allows the amplification of DNA fragments as
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long as 20 Kb, the size of DNA fragment obtained by the real-time PCR is not longer than 150
bp which cannot be used for pos-PCR analysis. The specificity of a real-time PCR product is
determined by the use of Carl Wittwer’s melting curve analysis [17] or by using dual fluores‐
cently labeled probes [18]. These improvements allowed the use of real-time PCR not only to
detect genotype [19, 20] but also to quantify the amplification product, to determine gene copy
numbers of pathogenic microorganisms and the expression of genes associated to infection
reactivation, virulence, genetic modification, etc. [21-24].
1.1.2. Advantages and drawbacks of single and multiple copy genes
The specificity and sensitivity of nucleic acid amplification techniques depend on the target
gene selection and the design of oligonucleotides. Once the gene target is elected, there are
several free available bioinformatic tools to check for the better sequence to be used in PCR
and real-time PCR reactions, mainly to avoid the formation of oligonucleotide self-hairpin
structure and primer−dimer arrangements. Thus, the principal challenge to obtain an accurate
molecular diagnosis based on nucleic acid amplification is the selection of the target genomic
sequence.
The biological features of the microorganism to be diagnosed are of critical importance to direct
the choice of an accurate gene target, including the life cycle, specific metabolic pathways,
genomic organization, and evolution. Knowledge on life cycle is principally important when
the purpose is the detection of stage-specific forms of a microorganism, as gametocytes of
Plasmodium in human blood [25]. In this case, the real-time PCR can detect the expression of
gametocyte-specific genes, and patients at risk to transmit malaria can be identified.
Particular metabolic pathways of a microorganism are usually associated to specific genes
which can be used as markers for the recognition of infectious agents [26-28]. Commonly, these
genes are in single copy in the genome and are highly expressed and evolutionarily conserved,
being excellent targets for real-time PCR diagnosis [29], as it is a highly sensitive nucleic acid
detection method.
Genomic organization and evolution are of principal interest to select gene targets that are not
in strong structured regions of the genome [30] and whose sequence is beneath strong selective
pressure, being highly conserved. Usually, multiple-copy genes as ribosomal and transporter
RNA coding sequences are used as template for diagnostic methods in order to obtain high
sensitivity with specificity. In this case, it is important to consider that RNA coding sequences
possess a high capability to form hairpins and are in a structured region of the genome, and
thus, even in high copy number, they can present a low sensitivity in PCR reactions. Also, as
ribosomal and transporter RNA coding sequences are very conserved among all groups of
organisms, decreasing sensitivity of the diagnostic test can occur depending on the selected
gene region. Thus, it is very important to perform a comparative analysis of the diagnostically
selected gene among phylogenetically closed groups of organisms and the host. Mitochondrial
genes are also largely used as gene targets due to their high copy number in eukaryotes;
however, their similarity with bacterial genome also has to be observed in order to obtain
specificity [31].
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1.1.3. Identification of drug resistance
After amplification of a target gene by PCR, several molecular strategies can be used to detect
nucleotide mutations, such as sequencing, restriction enzyme analysis, hybridization, etc. This
approach is useful to detect mutations associated to drug resistance directly on biological
samples without the requirement of culture isolation. Some antibiotics act in bacterial ribo‐
some, and the investigation of point mutations in ribosomal RNA coding sequences of
cultivable bacteria can be extended by Homology to fastidious growing pathogenic species.
One example is the fastidious cultivable bacteria Helicobacter pylori, the etiological agent of
gastritis and peptic ulcer diseases. There are several real-time PCR and pos-PCR methods for
clinical applications in order to determine resistance against the most important antibiotics
used for H. pylori treatment, including clarithromycin [32, 33] and tetracycline [34, 35].
The same kind of methodology is used to investigate genotypes of microorganisms associated
to pathogenicity, virulence, drug resistance, etc. As an example, genotype identification of HIV
[36, 37] and hepatitis C virus (HCV) [38] resistant to treatment with different inhibitors of viral
protease, directly on clinical samples, allow correct treatment of the patients. Another example
is the differentiation of the protozoa Entamoeba histolytica (pathogenic) from E. dispar (non-
pathogenic) and E. moshkovskii (non-pathogenic) in the intestinal tract of human, which can
only be performed genetically [39]. The correct identification of E. histolytica avoids unneces‐
sary treatment which, besides being expensive and capable of causing side effects to the
patient, permits selection of drug-resistant species.
1.2. Epidemiology
Nucleic acid approaches have improved epidemiology, a science that deals with etiology,
distribution, natural history, and control of diseases in humans [40]. In this section, some
aspects of the molecular epidemiology of infectious diseases will be discussed, including the
determination of etiological agents of diseases, association of genetic markers to transmission,
treatment efficiency, clinical outcome patterns, applicability of genetic diversity knowledge in
vaccine development, and the control/prevention of transmission of infectious agents.
Several genotyping techniques are mentioned in Section 1.1, and the same approaches can be
used in order to determine the genetic variability. However, the development of enzymatic
nucleic acid sequence determination with the use of chain-terminating inhibitors by Sanger
[41] and its rapid automation allowed a prompt availability of gene sequences of several
infectious agents and their hosts. More recently, next-generation sequencing methods associ‐
ated to powerful bioinformatic tools have made complete sequences of small genomes of
pathogenic virus and bacteria accessible during the occurrence of an epidemic or outbreak.
These techniques will be briefly presented in Section 1.2.1.
Epidemiological studies on the association of pathogens and host genetic variability to disease
susceptibility and pathogenicity/virulence can help to prevent and treat several infectious
diseases (Section 1.2.2.). Moreover, the determination of genetic variability of infectious agents,
antigens, and host population are useful for vaccine development (Section 1.2.3).
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1.2.1. Classic genotyping and next-generation sequencing methods
Different from the diagnostic methods, where molecular markers are desired to be conserved
among all individuals of a species, for population genetic epidemiological studies, the most
important marker characteristics are individual high variability and neutral evolution. Nucleic
acid-based conventional genotyping of microorganisms can be carried out by hybridization
and amplification approaches as already described in Section 1.1. Moreover, the most classical
molecular approaches used for epidemiological studies include restriction fragment length
polymorphism (RFLP), macrorestriction analysis [42], and alternative PCR and pos-PCR
techniques such as rapid amplification of polymorphic DNA (RAPD), analysis of variable
number of tandem repeats (VNTR) [43], variation in repeated short motifs (microsatellites),
multilocus microsatellite typing (MLMT) [44, 45], single-strand conformation polymorphism
(SSCP) [46], etc. These techniques are valuable for epidemiological studies of bacteria and
protozoans, considering their genomic organization, structure, and large size. The detection
of single-nucleotide polymorphism (SNP) associated to specific populational characteristics
can be easily identified by sequencing. Also, in majority of viruses, which generally present a
small genome and lack of repetitive tandem organized sequences, complete genomic sequenc‐
ing is the genotyping method of choice for epidemiologic studies.
Genomic sequencing became possible for many biological applications after the development
of first-generation sequencing methods, comprising Maxam–Gilbert's base-specific chemical
cleavage [47] and Sanger's enzymatic reaction with chain terminator nucleotides, which is
widely used [41]. The improvement of Sanger sequencing method with the use of thermostable
proofreading DNA polymerases, fluorescent chain terminator nucleotides, and laser-based
equipment associated to capillary electrophoresis enabled its rapid automation and commer‐
cial availability. Therefore, Sanger's method allowed a revolution in genome sequence projects
of pathogenic microorganisms and other organisms, with high accuracy and a relatively low
rate [48-53]. The search for a more throughput sequencing technique to obtain large complete
genomic sequences, more rapidly and without purification or cloning of the nucleic acid of a
specific organism, leads to the development of second- and third-generation sequencing
methods.
The second-generation method was commercialized by Roche laboratories, the 454 Life Science
equipment, which was based on pyrophosphate detection during DNA synthesis performed
on an array composed of wells in a fiber-optic slide [54]. By this method, each well is filled
with one bead containing a single DNA molecule polymer produced by genomic sharing, and
primed at 3' and 5' ends with short sequence adaptors. DNA polymer attached to a bead is
immersed in an emulsion to be amplified by PCR in order to obtain a high number of molecules
to generate enough luminescence signals to be captured by a charge-coupled device (CCD)
imager coupled to the fiber-optic array. Before its attachment to the well, each amplified DNA
polymer is denatured with specific enzymes. Each sequence cycle consists of pyrophosphate
detection in each fiber-optic well, released after the addition of one of the four DNA bases and
captured by a luminescent reaction system and read at real time. Each well of the array
produces a collection of short sequences of approximately 40 bp which are assembled by
software with the use of a prototype Sanger-generated genomic sequence available in several
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public databanks. Roche laboratories discontinued the 454 Life Science which was replaced by
the improved FLX titanium XLR and XL+ capable of individual length read of 450 and 700 bp,
respectively. Other second-generation systems, characterized by the production of short
sequence arrays, are based on DNA synthesis with fluorescent terminator reversible nucleo‐
tides and exonucleases. A CCD imager collects the enzymatically cleaved incorporated specific
terminator fluorescent nucleotide, added by cycles of sequencing on primed DNA fragments,
produced by sharing and attached on a solid platform, where it is also amplified by PCR [55].
These technologies present certain limitations such as a relative high cost, low throughput,
and low sequence accuracy for large genomes, although being valuable for virus genomes [56].
Third-generation sequencing methodologies are in development, based on a technology called
single molecule real time (SMRT), which use biological nanopores, without the necessity to
amplify the target template [57]. All these next-generation sequencing techniques have been
improving, and certainly more accessible and accurate devices will be available in near future.
1.2.2. Genetic variability and its impact on pathology and virulence
Genetic variability determination in microorganisms, performed by different methodologies
as exemplified in Section 1.2.1, allows the identification of infectious disease distribution in
time and place, as well as the investigation of transmission patterns and clinical manifestation
and progression in affected populations. Knowledge of these factors is used for infectious
disease intervention and prevention strategies, as for example in dengue fever, caused by four
distinct serotypes of dengue virus (DENV1-4), belonging to the genus Flavivirus, family
Flaviviridae.
The clinical manifestation and progression of dengue patients vary from absence of symptoms
to a severe disease, mostly characterized by plasma leakage with or without hemorrhagic signs
[58]. According to several studies, symptoms and severity of dengue diseases are associated
to viral load, host immunity conditions, and the occurrence of antibody-dependent enhance‐
ment by heterologous DENV antibodies which are related to the number of previous serotypes
infections. DENV serotypes are related to genetic variation in the major antigenic envelope
and pre-membrane structural proteins. Thus, the characterization of DENV genetic variation
and evolution in these specific regions is of crucial importance to understand the disease
progress in an affected population.
Molecular epidemiological investigations, with sequencing of DENV 240 nucleotides of the
envelop and nonstructural 1 coding regions, revealed distinct genomic groups of DENV
serotypes 1 and 2, according to the geographical and temporal virus population circulation
[59], which was confirmed by complete genome sequencing [60]. The same strategy was used
to genetically characterize groups of DENV-3 and DENV-4, with distinct evolutionary
constraints which interfere in transmission and disease manifestation [61, 62]. Knowledge of
these characteristics has implications not only for control and disease management strategies
but also for vaccine development.
Microsatellite genomic sequences are useful for the treatment and control of infectious agents
by the identification of individual and group of clonally disseminated microorganisms. This
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kind of study enables the identification of relapses, drug-resistant pathogens, and clinically
distinct variants, as investigated in protozoan parasites such as Leishmania [45, 63] and
Plasmodium [64, 65]. The geographical dissemination of microorganisms can also be charac‐
terized by microsatellites studies [66, 67] helping in the characterization of transmission
patterns which can be used for control strategies.
Domestic and sylvatic animal sources of pathogenic microorganisms infecting human, with
or without clinical outcomes according to genetic variants, can also be investigated by
genotyping. Toxoplasmosis, an example of a zoonosis, is caused by Toxoplasma gondii, a
protozoan parasite with high genetic variability, from the apicomplexa group. Attempts to
identify genetic variants associated to specific animal hosts or clinical outcome fail; however,
it is possible to identify the source of parasite infection by genotyping with the use of multilocus
PCR and RFLP [68]. Using this methodology, a study on German patients revealed that ocular,
cerebral, and systemic toxoplasmosis presented predominance of T. gondii from lineage type
II, the same genotype found in parasite oocysts isolated from cats of the same geographic
region [69]. The prevalence of T. gondii lineages presents specific regional distribution, being
highly variable in South America [70], where the parasites are isolated from domestic and wild
animals, including chiropterans [71]. Based on these studies, it is possible to recognize several
potential parasite intermediate hosts and map the risk areas for toxoplasmosis transmission.
Chaga's disease caused by Trypanosoma cruzi, a protozoan parasite from the kinetoplastida
group, is also an excellent example of eco-epidemiologic study using genotyping. Parasites are
transmitted naturally to humans by the exposure of abraded skin to feces of triatomine bugs,
and they circulate in the wild in different sylvatic animals and triatomine species. There are
six principal genetic variants or discrete typing units of T. cruzi determined by multilocus PCR,
RFLP, and sequencing analysis, associated to geographical distribution and transmission
cycles [72-74]. The association of the outcome of Chaga's disease and specific parasite geno‐
types is still controversial; however, comparative investigation of T. cruzi genotypes in human
infections, sylvatic bugs, and animal reservoirs, in rural areas near forest, which is common in
South America, can reveal potential vectors and animal sources of infection.
1.2.3. Disease control and vaccines
The most effective means to control an infectious disease is a vaccine, which is still not available
for malaria, trypanosomiasis (Chaga's disease, sleeping sickness, leishmaniasis), and most of
arboviruses (dengue fever, chikungunya fever, etc.). The genetic variability of infectious
agents, a rapid genomic evolution in case of viruses, and several escape mechanisms from host
immune system selected along parasite–host interactions constitutes intricate drawbacks for
vaccine development. The problem of genetic prompt variability of virus genome can be
circumvented by systematic sequencing during epidemic periods such as the one successfully
made for influenza vaccine recommendation each year.
Influenza vaccine is composed of attenuated viruses produced in eggs, every year, following
the virus strain recommendation by World Health Organization, after monitoring genetic
variation in the gene encoding the surface protein hemagglutinin due to its antigenic properties
(http://www.who.int/influenza/vaccines/virus/recommendations/201502_recommenda‐
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tion.pdf?ua=1). Molecular epidemiological studies performed in different geographical
regions are used in order to obtain the recommended vaccine strains. Also, there are geo‐
graphical and populational differences in viral antigenic changes which should be taken into
consideration as described in China, where dominant antigenic influenza clusters change more
frequently than in the USA/Europe [75].
Dengue virus consists of a particular challenging agent for vaccine development since its
genetic variation is directly related to the severity of disease progress, due to the antibody-
dependent enhancement by heterologous previous DENV infection. Thus, geographical
regional circulation knowledge of DENV virus is essential to the success of a vaccine [61, 76].
Considering the high speed in data acquisition, second- and third-generation sequencing of
DENV circulating during interepidemic period could help to predict serotypes and its genetic
variants in next outbreak, contributing to vaccine development and testing.
2. Final Considerations
Economic and social impact of infectious diseases should be considered worldwide, princi‐
pally in developing countries, including necessity of medical care, vector control, people
morbidity with loss of working hours, and reduced tourism in affected areas. The increase in
population, high people mobility, and the lack of an effective vaccine against the most
disseminated infectious diseases, such as dengue fever, malaria, tripanosomiasis, etc., make
these human threats an important public health concern. Nucleic acid technologies have been
contributing to the knowledge of infectious disease transmission, distribution, clinical
manifestations, and progression, helping in its control and management. Several examples are
discussed in this chapter, and hopefully, it will stimulate readers to investigate these micro‐
biological intricacies and magnificent parasite–host interactions, more profoundly.
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